Translational Development Acquisition Corp. Ordinary Shares (TDAC) - Total Assets
Based on the latest financial reports, Translational Development Acquisition Corp. Ordinary Shares (TDAC) holds total assets worth $179.98 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Translational Development Acquisition Corp. Ordinary Shares - Total Assets Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares's total assets have evolved over time, based on quarterly financial data. Also see how much is Translational Development Acquisition Co worth for the company's overall valuation and market capitalisation.
Translational Development Acquisition Corp. Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
Translational Development Acquisition Corp. Ordinary Shares's total assets of $179.98 Million consist of 0.4% current assets and 99.6% non-current assets. Review Translational Development Acquisition Co total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $12.57 Trillion | 7182356.2% |
| Goodwill | $9.06 Trillion | 5178082.9% |
Asset Composition Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See TDAC live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Translational Development Acquisition Corp. Ordinary Shares's current assets represent 0.4% of total assets in 2024, a decrease from 12.4% in 2022.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2024, down from 0.5% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12360438.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is intangible assets at 7182356.2% of total assets.
Translational Development Acquisition Corp. Ordinary Shares Competitors by Total Assets
Key competitors of Translational Development Acquisition Corp. Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
RF Acquisition Corp III Ordinary Shares
NASDAQ:RFAM
|
USA | $102.22 Million |
|
SDCL EDGE Acquisition Corporation
NYSE:SEDA
|
USA | $147.80 Million |
|
EQV Ventures Acquisition Corp.
NYSE:EQV
|
USA | $367.18 Million |
|
Centurion Acquisition Corp.
NASDAQ:ALF
|
USA | $310.95 Million |
|
MOZAYYX Acquisition Corp.
NYSE:MZYX
|
USA | $302.49 Million |
|
Archimedes Tech SPAC Partners II Co. Unit
NASDAQ:ATIIU
|
USA | $241.35 Million |
|
Sizzle Acquisition Corp. II - Class A ordinary shares
NASDAQ:SZZL
|
USA | $239.81 Million |
|
Spring Valley Acquisition Corp. IV Class A Ordinary Shares
NASDAQ:SVIV
|
USA | $232.30 Million |
Translational Development Acquisition Corp. Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.19 | 0.23 | 0.61 |
| Quick Ratio | 0.19 | 0.23 | 0.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-342.26K | $-740.36K | $-40.30K |
Translational Development Acquisition Corp. Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Translational Development Acquisition Corp. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 1.07 |
| Asset Growth Rate (YoY) | 8659008.3% |
| Total Assets | $175.00 Million |
| Market Capitalization | $187.08 Million USD |
Valuation Analysis
Above Book Valuation: The market values Translational Development Acquisition Corp. Ordinary Shares's assets above their book value (1.07x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Translational Development Acquisition Corp. Ordinary Shares's assets grew by 8659008.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
The table below shows the annual total assets of Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $175.00 Million | +8659008.31% |
| 2023-12-31 | $2.02K | -99.54% |
| 2022-12-31 | $437.24K | -- |
About Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.